Hubs
Select Options
- Biopharmaceutical companies – Representation of multinational, mid-size, and start-up biopharmaceutical companies in connection with strategic portfolio development; licensing; and IP diligence matters; advising on Inter partes review proceedings (as petitioner and patent holder); Orange Book and Hatch-Waxman litigation
- Consumer products companies – Strategic portfolio management in formulations, biotechnology, device and related hi-tech divisions; IP diligence associated with M&A matters; clearance assessments; opinion and pre-litigation assessments; advising on Inter partes review proceedings
- Specialty products chemical manufacturers – Portfolio development; targeted diligence; and clearance assessments
- University clients – Development of patent prosecution strategies; licensing negotiations and drafting; inventorship disputes
- Chemical development and processing manufacturers – licensing negotiations; clearance assessments; mediation; appellate matters